|
|
|
|
The possibility of ameliorating the consequences of an acute ischemic stroke by pretreating high-risk patients with appropriate neuroprotective agents needs to be explored.Several types of high-risk population for prophylactic neuroprotection can be envisioned and then studied in clinical trials. |
|